Explore 4-Propylthio-2,5-dimethoxyamphetamine

PiHKAL book II entry ALEPH-7

ChemSpider 9372590
PubChem 11197521
Wikipedia Aleph (psychedelic)

Shulgin Index #6 ALEPH-7 · Table 5Page 345Row 29

Phenethylamine: Von der Strucktur zur Funktion ALEPH-7: 8.5 (171) 795, 796, 836 · 8.5 808

Gallardo-Godoy, A; Fierro, A; McLean, TH; Castillo, M; Cassels, BK; Reyes-Parada, M; Nichols, DE. Sulfur-substituted α-alkyl phenethylamines as selective and reversible MAOA inhibitors: Biological activities, CoMFA analysis, and active site modeling J. Med. Chem., 1 Jan 2005, 48 (7), 2407–2419. 901 kB. https://doi.org/10.1021/jm0493109 #8c MS,NMR

Zhang, S; Fan, Y; Shi, Z; Cheng, S. DFT-based QSAR and action mechanism of phenylalkylamine and tryptamine hallucinogens Chin. J. Chem., 1 Apr 2011, 29 (4), 623–630. 166 kB. https://doi.org/10.1002/cjoc.201190132 #34

King, LA. New phenethylamines in Europe Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570

Shulgin, AT. Basic Pharmacology and Effects In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.

Shulgin, AT. Chemistry of psychotomimetics In Handbook of Experimental Pharmacology. Psychotropic Agents, Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs; Hoffmeister, F; Stille, G, Eds., Springer-Verlag, Berlin, 1 Jan 1982; Vol. 55 (3), pp 3–29. 928 kB. https://doi.org/10.1007/978-3-642-67770-0_1 #10gg

Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 74–91. 51 kB.

Shulgin, AT. Hallucinogens In Burger’s Medicinal Chemistry, 4th ed., Part III; Wolff, ME, Ed., John Wiley & Sons, Inc., 1 Jan 1981; pp 1109–1137. 4.7 MB. #22z

Clare, BW. The frontier orbital phase angles: Novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens J. Med. Chem., 24 Sep 1998, 41 (20), 3845–3856. 239 kB. https://doi.org/10.1021/jm980144c #85

Reyes-Parada, M; Iturriaga-Vasquez, P; Cassels, BK. Amphetamine derivatives as monoamine oxidase inhibitors Front. Pharmacol., 23 Jan 2020, 10 1590. 1.9 MB. https://doi.org/10.3389/fphar.2019.01590 #4-PrS-DMA

2,5-Dimethoxy-4-isopropylthioamphetamine · ALEPH-4

2C-T-9 · 4-tert-Butylthio-2,5-dimethoxyphenethylamine

2C-T-17 · 4-sec-Butylthio-2,5-dimethoxyphenethylamine · NIMITZ

4-Thiobuscaline · TB

3-T-TRIS · 3-Thiotrisescaline

4-T-TRIS · 4-Thiotrisescaline

2,5-Diethoxy-4-ethylthiophenethylamine · 2CT2-2,5-DIETO

2-Ethoxy-5-methoxy-4-isopropylthiophenethylamine · 2CT4-2ETO

2-Ethoxy-5-methoxy-4-propylthiophenethylamine · 2CT7-2ETO

2,5-Dimethoxy-N-methyl-4-propylthiophenethylamine · METHYL-2C-T-7

2C-T-19 · 4-Butylthio-2,5-dimethoxyphenethylamine

2C-T-25 · 4-Isobutylthio-2,5-dimethoxyphenethylamine

N-Me-4C-T · α-Ethyl-N-methyl-4-methylthio-2,5-dimethoxyphenethylamine

4-Ethylthio-2,5-dimethoxymethamphetamine · N-Me-ALEPH-2

4C-T-2 · α-Ethyl-4-ethylthio-2,5-dimethoxyphenethylamine

2,4,5-2C-T-7 · 2,4-Dimethoxy-5-propylthiophenethylamine

4-(2-Methylthioethyl)-2,5-dimethoxyamphetamine · DOMeSEt

p2-223: ALEPH-7
p3-338: ALEPH-7